Valeant seeks new chief to replace Pearson

29 March 2016 - Deborah Wilkes

Archived

Valeant Pharmaceuticals International is seeking a new chief executive officer to replace Michael Pearson. The news comes less than a month after the troubled pharmaceutical company said Pearson had returned to the post following his recovery from a severe case of pneumonia.

Click tags below for more information on topics:

Bausch Health

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: